Comparison of P50 values of HbF cotreated with 2,3-BPG and phthalides vs that of HbA treated solely with 2,3-BPG
Effector . | HbA . | HbF . | ΔP50, mm Hg . |
---|---|---|---|
0.6 mM 2,3-BPG | 16.24 | 15.05 | −1.19 |
0.6 mM 2,3-BPG + 0.6 mM z-butylidenephthalide | – | 16.30 | 0.06 |
4 mM 2,3-BPG | 18.83 | 16.56 | −2.27 |
4 mM 2,3-BPG + 2.5 mM z-butylidenephthalide | – | 18.63 | 0.20 |
4 mM 2,3-BPG + 4 mM z-butylidenephthalide | – | 19.54 | 0.71 |
4 mM 2,3-BPG + 4 mM z-ligustilide | – | 18.74 | 0.09 |
Effector . | HbA . | HbF . | ΔP50, mm Hg . |
---|---|---|---|
0.6 mM 2,3-BPG | 16.24 | 15.05 | −1.19 |
0.6 mM 2,3-BPG + 0.6 mM z-butylidenephthalide | – | 16.30 | 0.06 |
4 mM 2,3-BPG | 18.83 | 16.56 | −2.27 |
4 mM 2,3-BPG + 2.5 mM z-butylidenephthalide | – | 18.63 | 0.20 |
4 mM 2,3-BPG + 4 mM z-butylidenephthalide | – | 19.54 | 0.71 |
4 mM 2,3-BPG + 4 mM z-ligustilide | – | 18.74 | 0.09 |
▵P50 = (P50 of HbF cotreated with 2,3-BPG and chosen phthalide) – (P50 of HbA treated solely with 2,3-BPG at the same level).